Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
30%
OVERLAP
BY WEIGHT
32
# OF OVERLAPPING
HOLDINGS
WDNA
90
HOLDINGS
38%
ALSO IN XBI
XBI
116
HOLDINGS
28%
ALSO IN WDNA
SECTOR DRIFT (WDNA minus XBI)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in WDNA |
Weight in XBI |
Overlap | |
|---|---|---|---|---|
 |
ALNYLAM PHARMACEUTICALS INC | 3.0% | 3.5% | 3.0% |
|
BRIDGEBIO PHARMA, INC. | 4.0% | 2.3% | 2.3% |
|
NATERA INC | 4.4% | 2.2% | 2.2% |
|
UNITED THERAPEUTICS CORP | 2.2% | 3.3% | 2.2% |
|
IONIS PHARMACEUTICALS, INC. | 2.1% | 2.1% | 2.1% |
WDNA Overweight Relative to XBI
|
BLUEPRINT MEDICINES CORP. | 3.8% |
 |
NOVOZYMES A/S-B SHARES | 3.2% |
|
ELI LILLY & CO | 2.3% |
|
NATERA INC | 2.2% |
|
STOKE THERAPEUTICS, INC. | 2.0% |
 |
NOVARTIS AG | 1.9% |
|
AGIOS PHARMACEUTICALS INC | 1.7% |
|
TWIST BIOSCIENCE CORP. | 1.7% |
|
BRIDGEBIO PHARMA, INC. | 1.7% |
|
LABCORP HOLDINGS | 1.7% |
WDNA Underweight Relative to XBI
|
INSMED INC | -3.3% |
|
HALOZYME THERAPEUTICS INC | -3.2% |
|
INCYTE CORP | -2.7% |
|
NEUROCRINE BIOSCIENCES INC | -2.5% |
|
ABBVIE INC | -2.5% |
|
MADRIGAL PHARMACEUTICALS, INC. | -2.5% |
|
EXELIXIS INC | -2.1% |
|
CYTOKINETICS INC | -2.0% |
 |
ROIVANT SCIENCES LTD. | -1.9% |
|
BIOGEN IDEC INC | -1.8% |